Contact Information: Contact: Brian Keogh 425-453-9400
Esterline Technologies Corporation Agrees to Sell 3,450,000 Shares of Common Stock
| Source: Esterline Technologies
BELLEVUE, WA--(Marketwire - October 10, 2007) - Esterline Technologies Corporation (NYSE : ESL )
(www.esterline.com), a leading specialty manufacturer serving
aerospace/defense markets, announced today that it has agreed to sell
3,450,000 shares of its common stock at an initial public offering price of
$55.00 per share in an underwritten public offering. Net proceeds from the
offering are expected to be used to repay outstanding debt under credit
facilities and for general corporate purposes. The sale will be made under
Esterline's effective shelf registration statement previously filed with
the Securities and Exchange Commission. The sole underwriter for the
offering is Jefferies & Company, Inc.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of these
securities in any state or jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
A copy of the final prospectus supplement relating to the offering may be
obtained, when available, from Jefferies & Company, Inc., Equity Capital
Markets, 520 Madison Avenue, New York, NY 10022: 1-888-449-2342.
This press release contains "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. In some cases, you
can identify forward-looking statements by terminology such as
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "might," "plan," "potential," "predict," "should" or
"will," or the negative of such terms, or other comparable terminology.
These forward-looking statements are based on the current intent and
expectations of the management of Esterline, are not guarantees of future
performance or actions, and involve risks and uncertainties that are
difficult to predict. Esterline's actual results and the timing and outcome
of events, including the offering and the use of proceeds from the
offering, may differ materially from those expressed in or implied by the
forward-looking statements due to risks and uncertainties such as those
detailed in Esterline's public filings with the Securities and Exchange
Commission, including the final prospectus supplement referenced above.